comscorePlanning Your Treatment

Planning Your Treatment

99 Research news
 
 
Article
Lumpectomy Plus Radiation May Offer Survival Benefits for Early-Stage Disease

Another study suggests that lumpectomy plus radiation may offer survival benefits for some women diagnosed with early-stage disease.

 
Article
Treating Inflammatory Breast Cancer With Surgery, Chemotherapy, and Radiation Improves Survival

A study has found that women diagnosed with inflammatory breast cancer who are treated with chemotherapy, surgery, and radiation have better survival rates than women who don't receive all three treatments.

 
Article
ASCO Issues Guidelines on Using Biomarkers to Make Adjuvant Treatment Decisions for Women Diagnosed With Early-Stage Invasive Disease

ASCO has put out new guidelines on using biomarkers to make decisions about treatments after surgery for women diagnosed with early-stage invasive breast cancer.

 
Article
Tamoxifen Gel Reduces DCIS Recurrence Risk as Well as Tamoxifen Pills

A small, early study found that a tamoxifen gel applied directly to the breast area of women diagnosed with DCIS stopped cancer cell growth as well as tamoxifen pills and caused fewer side effects.

 
Article
Many Younger Women Don't Think Hormonal Therapy Is Necessary

Many young women don't think hormonal therapy is an essential treatment for breast cancer, which may be why they stop the treatment early.

 
Article
More Women Having Double Mastectomy, but Survival Rates Are Same as Lumpectomy Plus Radiation

Women diagnosed with early-stage breast cancer in one breast who are treated with lumpectomy followed by radiation therapy have the same survival rates as women who are treated with double mastectomy.

 
Article
Senate Bill Would Require at Least 48 Hours of Hospital Care After Breast Cancer Surgery

U.S. legislators are considering two bills -- one on minimum hospital stays after breast cancer surgery and one on federal funding for environmental links to breast cancer -- that may have a big effect on women diagnosed with the disease.

 
Article
How Do Diagnosed Young Women Make Decisions About Having Opposite Healthy Breast Removed?

A small study has found that most younger women diagnosed with early-stage breast cancer who decide to have the other healthy breast removed choose the surgery because they want to reduce their risk of breast cancer developing in the other breast and improve their survival, even though most of them know that removing the other healthy breast doesn't really improve survival rates in women without an abnormal breast cancer gene.

 
Article
Postmenopausal Women Benefit From Longer Hormonal Therapy

Taking Arimidex for 3 years after 5 years of tamoxifen reduced the risk of the cancer coming back in women diagnosed with hormone-receptor-positive breast cancer.

 
Article
Tamoxifen Plus Removing Ovaries Improves Survival for Premenopausal Women

Removing the ovaries and taking tamoxifen after breast cancer surgery had benefits for premenopausal women shows a new study done in Vietnam and China.

 
Article
Surgeon Characteristics Affects Whether Women Get Radiation After Lumpectomy

Surgeons' characteristics seem to affect whether women receive radiation therapy after lumpectomy.

 
Article
DCIS Recurrence Risk Overestimated by Many Women

Many women overestimate the risk of DCIS coming back.

 
Article
Older Women, Minorities Less Likely to Get Sentinel Node Biopsy

Whether or not a woman has sentinal lymph node biopsy seems to be largely influenced by her age, ethnicity, and insurance status, and not by the relevant disease factors, new research shows.

 
Article
Protective Mastectomy and Ovary Removal Can Be Done at Same Time

A small study suggests that prophylactic (protective) breast and ovary removal can be done safely during one surgery.

 
Article
Women Whose Breasts Look Different From Each Other After Lumpectomy More Likely to Feel Bad

Women whose breasts look significantly different from each other after lumpectomy are more likely to be depressed and feel ashamed of their bodies.

 
Article
Many Women Don't Understand Treatment Risks and Benefits

Research suggests that many women diagnosed with early-stage breast cancer don't understand the differences in risks and benefits between mastectomy and lumpectomy and radiation therapy.

 
Article
Breast Cancer May Come Back Even Many Years After Treatment

A new study shows that breast cancers that are hormone-receptor-positive and later-stage are more likely to come back later than 5 years after diagnosis and treatment compared to cancers that are hormone-receptor-negative and early-stage.

 
Article
If Cancer Comes Back After Lumpectomy, Mastectomy May Be Best Choice

Women who had lumpectomy to treat an initial breast cancer and then had lumpectomy again to treat breast cancer that came back in the same breast had lower survival rates in the 10 years after the second surgery compared to women who had lumpectomy as the first surgery and then mastectomy as the second surgery.

 
Article
Reconstruction With Implant Immediately After Mastectomy Affected More by Radiation

A small study suggests that reconstruction done immediately after mastectomy using tissue from the body offers better results after radiation compared to immediate reconstruction using implants.

 
Article
Arimidex Still Better Than Tamoxifen After Surgery to Reduce Recurrence Risk

After 10 years of follow-up, research shows that 5 years of Arimidex is better at reducing the risk of hormone-receptor-positive breast cancer recurrence than 5 years of tamoxifen.

 
Article
Research Says Lymphedema Risk Is Ongoing

New research suggests that lymphedema may be more common and last longer than generally thought.

 
Article
Chemo and Radiation Before Surgery Seems to Reduce Risk of Recurrence for Certain Breast Cancers

Research suggests that giving BOTH chemotherapy and radiation therapy before surgery to remove locally advanced breast cancer can help reduce the risk of the cancer coming back in the breast area in the 5 years after surgery.

 
Article
Aromatase Inhibitors Increase Risk of Heart Problems

Women diagnosed with early-stage, hormone-receptor-positive breast cancer who got 5 years of an aromatase inhibitor seem to be more likely to have heart problems compared to women who got 5 years of tamoxifen.

 
Article
Arimidex and Aromasin Equally Good at Reducing Recurrence Risk

A new study shows that Arimidex and Aromasin are equally good at reducing the risk of recurrence in postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer.

Showing 24 of 99